To check the function of serum-containing MSJZD on the migration and invasion in NSCLC cells triggered by TGF-β1, we utilized 5 ng/ ml TGF-β1 and different doses of serum-containing MSJZD to treat cells. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.